0001639643-16-000004.txt : 20160803 0001639643-16-000004.hdr.sgml : 20160803 20160803133551 ACCESSION NUMBER: 0001639643-16-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160803 DATE AS OF CHANGE: 20160803 EFFECTIVENESS DATE: 20160803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kalytera Therapeutics, Inc. CENTRAL INDEX KEY: 0001639643 IRS NUMBER: 471374952 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-268236 FILM NUMBER: 161803234 BUSINESS ADDRESS: STREET 1: 245 33RD STREET CITY: HERMOSA BEACH STATE: CA ZIP: 90254 BUSINESS PHONE: 8888612008 MAIL ADDRESS: STREET 1: 245 33RD STREET CITY: HERMOSA BEACH STATE: CA ZIP: 90254 D 1 primary_doc.xml X0707 D LIVE 0001639643 Kalytera Therapeutics, Inc. 500 S. Sepulveda Blvd., Suite 212 Manhattan Beach CA CALIFORNIA 90266 888-861-2008 DELAWARE None None Corporation true 2014 Seth Yakatan c/o Kalytera Therapeutics, Inc. 500 S. Sepulveda Blvd., Suite 212 Manhattan Beach CA CALIFORNIA 90266 Executive Officer Director Chief Executive Officer David Stefansky c/o Kalytera Therapeutics, Inc. 500 S. Sepulveda Blvd., Suite 212 Manhattan Beach CA CALIFORNIA 90266 Director Chairman of the Board Farrell Robert c/o Kalytera Therapeutics, Inc. 500 S. Sepulveda Blvd., Suite 212 Manhattan Beach CA CALIFORNIA 90266 Executive Officer Director President, Chief Operating Officer and Chief Financial Officer Victoria Rudman c/o Kalytera Therapeutics, Inc. 500 S. Sepulveda Blvd., Suite 212 Manhattan Beach CA CALIFORNIA 90266 Executive Officer Secretary Ronald Erickson c/o Kalytera Therapeutics, Inc. 500 S. Sepulveda Blvd., Suite 212 Manhattan Beach CA CALIFORNIA 90266 Director Jerome Zeldis c/o Kalytera Therapeutics, Inc. 500 S. Sepulveda Blvd., Suite 212 Manhattan Beach CA CALIFORNIA 90266 Director Jeffrey Paley c/o Kalytera Therapeutics, Inc. 500 S. Sepulveda Blvd., Suite 212 Manhattan Beach CA CALIFORNIA 90266 Director Other Decline to Disclose 06b false 2016-07-19 false true true false 50000 Newbridge Securities 0052 Dawson James Securities, Inc. 130645 530 5th Avenue 21St FL 44th-45th Street New York NY NEW YORK 10036 FL FLORIDA NY NEW YORK false Newbridge Securities 0052 Cova Capital Partners LLC 109761 6851 Jericho Tpke, Suite 130 Syosset NY NEW YORK 11791 FL FLORIDA NY NEW YORK false 2400000 250750 2149250 Total offering amount includes $400,000 to cover any over-allotments over the maximum offering amount of $2,000,000. false 4 288000 true 0 0 false Kalytera Therapeutics, Inc. /s/ Seth Yakatan Seth Yakatan Chief Executive Officer 2016-08-02